Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 4INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 1Breast 1

Conditions

Secondary Malignant Neoplasm of Bone 1Breast Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × INDUSTRY × High-Intensity Focused Ultrasound Ablation × Clear all
NCT00008437 2012-07-02

MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer

InSightec

Phase 2 Completed
Breast

Breast Neoplasms

NCT01117246 2012-02-20

Pilot Study for Palliation of Pain in Bone Metastases by MR-HIFU

Philips Healthcare

Phase 1/2 Completed
2 enrolled
Other neoplasm

Secondary Malignant Neoplasm of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡